Title: Fluorescence Deconvolution Tomography: Novel technology to study millions of synapses in brain

**Abstract**

This presentation will review evidence that communication within and between cortical networks is mediated by fast excitatory glutamatergic transmission, and evidence that disturbances in this fundamental feature of cortical processing is critical in the pathophysiology of major depressive disorders (MDD). It will focus on a new brain imaging technology, fluorescence deconvolution tomography (FDT), which has been developed for the measurement and visualization of very large numbers (\~1 million) of individual excitatory contacts labeled with anti-sera against the postsynaptic density protein, PSD95. PSD95 plays a vital role in positioning glutamate receptors as well as maintaining integrity of the postsynaptic component of the synaptic junction. The FDT technology has recently been applied to study synaptic abnormalities in a rat model of congenital depression (learned helplessness). Rats were bred for depressive-like behavior and for resilience. This research characterized excitatory synapses in layer I of the infralimbic cortex \[an area homologous to the anterior cingulate (ACC) in man and a region relevant to major depressive disorder. For each rat, 250,000 synapses were 3D reconstructed. Three groups were studied: (1) rats bred for learned helplessness (cLH); (2) rats resilient to learned helplessness (cNLH); and (3) control Sprague Dawley rats. In fields within the infralimbic cortex, learned helplessness (cLH) rats had the same numerical density of synapses, immunolabeled for either the postsynaptic density marker PSD95 or the presynaptic protein synaptophysin, as controls. However, importantly, PSD95 immunolabeling intensities were substantially lower in cLH rats. In contrast, the resilient rats (cNHL) had 25% more PSD95 immunolabeled intensity than either cLH (learned helplessness) or control rats without an increase in synaptophysin-labeled terminal frequency. These results suggest that depression-like behavior may differentially modulate excitatory synapses. Preliminary investigations have demonstrated the feasibility of using this technology in postmortem brain tissue from the ACC in major depressive disorder patients and controls, to assess the number of synapses labeled with PSD95, density of PSD concentrations, and the size of excitatory synapses. This study could provide novel data that could substantially contribute to our understanding of the role of glutamatergic function in MDD.
